Table 3

Follow-up (6–37 months)

No. of patients

%

NED

12

41.3%

AWSP

2

6.7%

DOD

7

24.1%

DOSP

6

20.7%

DOC

2

6.7%

NED No evidence of disease AWSP Alive with secondary primary DOD Dead of disease DOSP Dead of second primary DOC Dead of other causes

Benazzo et al. BMC Cancer 2002 2:13   doi:10.1186/1471-2407-2-13